Annual Book Value
-$911.00 K
-$51.22 M-101.81%
31 December 2023
Summary:
Spyre Therapeutics annual book value is currently -$911.00 thousand, with the most recent change of -$51.22 million (-101.81%) on 31 December 2023. During the last 3 years, it has fallen by -$84.85 million (-101.09%). SYRE annual book value is now -100.65% below its all-time high of $139.83 million, reached on 01 December 2020.SYRE Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
$171.57 M
-$46.99 M-21.50%
30 September 2024
Summary:
Spyre Therapeutics quarterly book value is currently $171.57 million, with the most recent change of -$46.99 million (-21.50%) on 30 September 2024. Over the past year, it has increased by +$416.97 million (+169.91%). SYRE quarterly book value is now -21.50% below its all-time high of $218.56 million, reached on 30 June 2024.SYRE Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -101.8% | +169.9% |
| 3 y3 years | -101.1% | +104.4% |
| 5 y5 years | -101.5% | +185.6% |
SYRE Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -101.1% | at low | -21.5% | +169.9% |
| 5 y | 5 years | -100.7% | at low | -21.5% | +169.9% |
| alltime | all time | -100.7% | +95.9% | -21.5% | +169.9% |
Spyre Therapeutics Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $171.57 M(-21.5%) |
| June 2024 | - | $218.56 M(-769.3%) |
| Mar 2024 | - | -$32.66 M(+3484.9%) |
| Dec 2023 | -$911.00 K(-101.8%) | -$911.00 K(-99.6%) |
| Sept 2023 | - | -$245.40 M(+18.3%) |
| June 2023 | - | -$207.37 M(-716.2%) |
| Mar 2023 | - | $33.65 M(-33.1%) |
| Dec 2022 | $50.30 M(-40.1%) | - |
| Dec 2022 | - | $50.30 M(-25.5%) |
| Sept 2022 | - | $67.56 M(-19.7%) |
| June 2022 | - | $84.16 M(+36.5%) |
| Mar 2022 | - | $61.66 M(-26.5%) |
| Dec 2021 | $83.94 M(-40.0%) | $83.94 M(-17.8%) |
| Sept 2021 | - | $102.08 M(-14.2%) |
| June 2021 | - | $119.02 M(-3.8%) |
| Mar 2021 | - | $123.75 M(-11.5%) |
| Dec 2020 | $139.83 M(+132.7%) | $139.83 M(+2.6%) |
| Sept 2020 | - | $136.27 M(-10.5%) |
| June 2020 | - | $152.26 M(+255.7%) |
| Mar 2020 | - | $42.80 M(-28.8%) |
| Dec 2019 | $60.08 M | $60.08 M(-24.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | $79.80 M(-19.9%) |
| June 2019 | - | $99.61 M(-14.3%) |
| Mar 2019 | - | $116.29 M(+72.5%) |
| Dec 2018 | $67.43 M(+34.0%) | $67.43 M(+5.9%) |
| Sept 2018 | - | $63.68 M(-13.3%) |
| June 2018 | - | $73.45 M(+67.2%) |
| Mar 2018 | - | $43.92 M(-12.7%) |
| Dec 2017 | $50.34 M(-20.1%) | $50.34 M(-9.3%) |
| Sept 2017 | - | $55.51 M(-11.3%) |
| June 2017 | - | $62.60 M(+9.5%) |
| Mar 2017 | - | $57.18 M(-9.2%) |
| Dec 2016 | $62.97 M(-383.5%) | $62.97 M(-7.7%) |
| Sept 2016 | - | $68.20 M(-7.7%) |
| June 2016 | - | $73.92 M(-377.8%) |
| Mar 2016 | - | -$26.61 M(+19.8%) |
| Dec 2015 | -$22.21 M(+93.6%) | -$22.21 M(+19.0%) |
| Sept 2015 | - | -$18.66 M(+21.1%) |
| June 2015 | - | -$15.41 M(+9.1%) |
| Mar 2015 | - | -$14.13 M(+23.2%) |
| Dec 2014 | -$11.47 M(+801.3%) | -$11.47 M |
| Dec 2013 | -$1.27 M | - |
FAQ
- What is Spyre Therapeutics annual book value?
- What is the all time high annual book value for Spyre Therapeutics?
- What is Spyre Therapeutics annual book value year-on-year change?
- What is Spyre Therapeutics quarterly book value?
- What is the all time high quarterly book value for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly book value year-on-year change?
What is Spyre Therapeutics annual book value?
The current annual book value of SYRE is -$911.00 K
What is the all time high annual book value for Spyre Therapeutics?
Spyre Therapeutics all-time high annual book value is $139.83 M
What is Spyre Therapeutics annual book value year-on-year change?
Over the past year, SYRE annual book value has changed by -$51.22 M (-101.81%)
What is Spyre Therapeutics quarterly book value?
The current quarterly book value of SYRE is $171.57 M
What is the all time high quarterly book value for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly book value is $218.56 M
What is Spyre Therapeutics quarterly book value year-on-year change?
Over the past year, SYRE quarterly book value has changed by +$416.97 M (+169.91%)